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Abstract 
 
Background: Nocturnal hypokinesia is a decreased ability to perform sufficient axial rotation and/or 
trunk flexion to turn in or get out of bed. Currently, there are no validated questionnaires specifically 
to assess nocturnal hypokinesia in PD patients. 
Objective: To develop and validate a questionnaire to assess PD patients’ problems associated with 
turning or getting out of bed.  
Methods: The nocturnal hypokinesia questionnaire (NHQ) consists of 10 items, completed 
independently by patients and their caregivers. For validation, 76 patient-caregiver pairs completed 
the questionnaire and validity, agreement levels, and internal consistency assessed. In addition, 76 
healthy couples served as controls. The NHQ and Modified Parkinson’s Disease Sleep Scale (PDSS-
2) were compared and 25 random patients-caregiver pairs were also assessed with objective night-
time monitoring. 
Results: Patient and caregiver scores showed a high level of agreement (Intra-class correlation: 0.84) 
with high internal consistency (KR-20 coefficient of 0.73 for patients and 0.69 for caregivers). No 
significant difference between the mean total NHQ scores as rated by patients and caregivers was 
observed. Mean NHQ scores from patients and caregivers were significantly higher than healthy 
controls (p<0.001). Moderate correlations were found between the NHQ and PDSS-2 (r=0.32, 
p=0.004), and with objective monitoring (Number of turns: r=-0.41, p=0.04, Degree of turn r=-0.44, 
p=0.02). 
Conclusion: The NHQ is a reliable instrument to identify symptoms of nocturnal hypokinesia 
amongst PD patients. Strong patient-caregiver agreement supports the use of proxy evaluation by 
caregivers when patient’s information is unobtainable. 
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Introduction 
 
Nocturnal hypokinesia was recently defined as a decreased ability to perform sufficient axial rotation 
and/or trunk flexion to turn in or get out of bed [1]. However, in most cases, the problems related to 
night-time hypokinesia are not limited to axial rotation and trunk flexion, but also include abnormal 
limb movements and postures while in bed, and a decreased ability to coordinate axial and limb 
muscles to perform such movements. In clinical practice, the evaluation of nocturnal hypokinesia in 
PD patients is usually based on clinical interviews and specific items of validated questionnaires, 
with a reported prevalence of at least 50% amongst moderate stage patients [2, 3]. Recently, 
continuous objective monitoring with body-worn sensors has provided another option to evaluate 
nocturnal mobility in patient’s bedroom environment, with the ability to measure certain 
characteristics in PD patients, such as fewer, smaller and slower turns, and increased episodes of 
getting out of bed due to nocturia when compared to age-matched controls [4]. However, the use of 
night-time monitoring is still limited to research and clinical trials, and has yet to be employed in 
clinical practice. 
 
Despite the availability of the abovementioned instruments, there is currently no single method that 
is capable of capturing the different dimensions of nocturnal hypokinesia, which, by definition, is not 
just limited to turning in bed, but also encompasses getting out of bed, limb movements and posture 
while in bed, and the ability and coordination of axial and limb muscles to perform such movements. 
Moreover, certain symptoms may occur as part of the manifestations of nocturnal hypokinesia or as a 
result of treatment and related side effects, such as pain, stiffness, or dyskinesia. These modalities are 
not included in any existing questionnaires that are commonly used to elicit night-time problems 
amongst PD patients. For example, only one out of 15 items of the Modified Parkinson’s Disease 
Sleep Scale (PDSS-2) inquire only one aspect of nocturnal hypokinesia (item #9: Did you feel 
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uncomfortable at night because you were unable to turn around in bed or move due to immobility?) 
[5]. Obtaining the information on nocturnal hypokinesia from patients retrospectively during 
interviews can also be a real challenge as, in most circumstances, they are unable to recall their 
night-time symptoms accurately. On the other hand, physicians often obtain patient’s night-time 
information from caregivers. Therefore, the objective of our study is to develop and validate 
nocturnal hypokinesia questionnaire (NHQ) that is completed independently by either PD patients or 
their caregivers to determine various aspects related to nocturnal hypokinesia as experienced by PD 
patients.  
 
Methods 
 
Questionnaire development    
Discussions were held between a group of five PD experts who specialise in the care of PD and sleep 
disorders (three movement disorder and sleep neurologists, two PD specialist nurses), and a PD 
patient representing Chulalongkorn PD support group together with his caregiver, to determine the 
process of constructing a new questionnaire, as well as potential domains of burden worth exploring. 
All members were bilingual and all healthcare professionals had extensive experience, of at least 5 
years, in the care of PD patients. In addition, one-on-one and group interviews were also conducted 
with patients and caregivers attending a local PD support group. The contents from all discussions 
were then transcribed and analysed to determine four PD-specific themes that are related to nocturnal 
hypokinesia, including turning over in bed, getting out of bed, parkinsonian motor symptoms, and 
others (Supplementary data 1). Finally, ten items were generated for the NHQ, covering these four 
domains (Supplementary data 1). Each item was assigned a “yes/no” response for independent 
completion by patients and their caregivers based on their experience during the past week. The 
NHQ was then translated, according to translation standards, into Thai and back-translated into 
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English, with modifications of the Thai wordings where necessary. Comprehension of all items was 
tested for content validity by another expert panel who were not involved with item generation. The 
index of item-objective congruence (IOC) was conducted on all questionnaire items, demonstrating a 
positive content validation of IOC index at least 0.6 on all items (Supplementary data 2). 
 
Participants 
PD patients were included if their diagnosis was in accordance to the UK Brain Bank criteria. 
Caregivers were defined as spouses, relatives, or friends who identified themselves as being 
primarily responsible for the care of the patient. The eligibility criteria included: age of at least 18 
years, being able to understand and complete the self-rating questionnaire, and being clinically stable 
without a history of profound dementia or psychiatric disorders. In our setting, only caregivers who 
share the same bedroom environment with the patients were included in the study. Consent for 
participating in the study was obtained from all participants. Sample size was calculated by using 
medium effect size (Cohen’s d = 0.5), desired statistical level of 0.8, and probability level of 0.05, 
giving the minimum sample size of 64 in each group. For the validation, 76 PD patient-caregiver 
pairs were recruited from the movement disorder outpatient clinic at Chulalongkorn Centre of 
Excellence for Parkinson’s Disease and Related Disorders (ChulaPD, www.chulapd.org) between 
July and December 2017. Another set of 76 healthy couples served as controls. Ethical approval was 
given by the Human Ethics Committee of the Faculty of Medicine, Chulalongkorn University and 
the study was executed in accordance with the declaration of Helsinki. All patients provided written 
informed consent. 
 
Instruments 
In order to assess the NHQ against established measures of nocturnal symptoms in PD, all PD 
subjects were asked to complete the PDSS-2 and the Nocturnal Akinesia, Dystonia, and Cramp Score 
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(NADCS). The PDSS-2 is the modified version of the PDSS, recommended by the Movement 
Disorder Society (MDS) for rating overall sleep problems both to screen and to measure severity [5, 
6]. All 15 items in the PDSS-2 are divided into three factor categories, representing motor symptoms 
at night, PD symptoms at night, and disturbed sleep respectively. Item# 9, referring to the difficulty 
of turning in bed as a result of nocturnal immobility, belongs to the category of PD symptoms at 
night. The NADCS has three components, exploring the severity of akinesia, dystonia, and cramp 
during the night via an ordinal scale [7]. In addition, a random sample of 25 patients-caregivers pairs 
were also assessed with night-time sensor monitoring (the NIGHT-Recorder, ChulaPD, Thailand) to 
provide objective correlations [4, 8]. Objective nocturnal parameters in this study consisted of the 
number of times, degree, velocity and acceleration of turning in bed as described in our prior study 
[4].  
 
Statistical analysis 
 
Comparison of demographic data and clinical rating scales between groups were determined by 
Mann-Whitney U test. Chi-Square test was used to analyse relationships between categorical 
variables. Inter-rater agreement levels were assessed by Intra-class correlation for continuous 
variables, and Cohen’s Kappa coefficient for ordinal variables. Kuder-Richardson 20 (KR-20) 
coefficient was used to determine the internal consistency of the NHQ according to the dichotomous 
options of response of the items. To evaluate the external validity of the NHQ, Spearman’s rank 
correlation coefficient was calculated for correlations between the NHQ and the PDSS-2, NADCS, 
and objective data from sensor monitoring. A p-value less than 0.05 was considered statistically 
significant. Statistical analysis was performed using SPSS version 22.0 software (SPSS Inc., Chicago 
IL). 
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Results 
 
Sample characteristics 
Table 1 outlines the characteristics of the 76 PD patient-caregiver pairs. The majority of caregivers 
were female spouses sharing the same bedroom environment. All 76 healthy couples were non-
smokers and were without significant existing medical conditions. 
 
NHQ questionnaire feasibility 
The feasibility and face validity of the NHQ were established during interviews with neurologists, 
caregivers, patients, and healthy couples at the time of questionnaire development and during the 
recruitment stages of the study. All subjects took approximately ten minutes to complete the NHQ, 
and all respondents were able to finish the NHQ once they had started it. 
 
The NHQ characteristics can be seen in table 2. The item rating of each item was either ‘Yes’ (1) or 
‘No’ (0) and the mean total score of NHQ as rated by PD patients was not significantly different 
from the score rated by the caregivers (Patients: 4.57 + 2.54 vs. Caregivers: 4.28 + 2.40, p=0.10). 
However, both patients’ and caregivers’ scores were significantly higher than the healthy couples’ 
scores (p<0.001), confirming the specificity of NHQ items for nocturnal hypokinesia as experienced 
by PD patients. The distribution of this score indicates mild to moderate symptoms of nocturnal 
hypokinesia for most patients. Importantly, the internal consistency of the NHQ items was good, as 
confirmed by KR-20 coefficient of 0.73 and 0.69 for patients and caregivers respectively 
(Supplementary data 3). Therefore, all ten items were included in a final version of the NHQ. 
  
Inter-rater agreement between PD patients and caregivers 
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The Intra-class correlation coefficient for the total NHQ score, when rated by patients and caregivers 
as a measure of interrater agreement, was 0.84, demonstrating a good agreement for the NHQ when 
rated by either PD patients or their caregivers (Supplementary data 4). When considering the 
agreement of individual NHQ items, the strongest coefficient was observed for item #4 enquiring 
about the need for assistance to get out of bed (0.97), followed by item #5, which enquires about 
presence of axial stiffness during the night or in the early morning (0.76). However, the coefficient 
values of all NHQ items were above 0.4, indicating at least moderate strength of agreement for all 
items. 
 
Convergent validity   
The convergent validity was supported by moderate correlations of the NHQ with the PDSS-2 
(r=0.32, p=0.004) as well as its PD symptoms at night sub-score (r=0.42, p<0.001), and PDSS item 
#9 on nocturnal immobility (r=0.37, p=0.001) (Supplementary data 5). Similar correlations were also 
observed between the NHQ and the NADCS total score and its sub-scores on akinesia and dystonia. 
In this study, we attempted to determine the correlation between the NHQ and the objective 
measurement of turning in bed in 25 PD subjects and their caregivers. Moderate correlations were 
also observed between the NHQ and the number of turns (r=-0.41, p=0.04) and the degree of turning 
in bed (r=-0.44, p=0.02) respectively (Supplementary data 5). 
 
Discussion 
 
In this study, we have developed the NHQ that is specific to PD and displays good content validity 
and reliability when implemented by either PD patients or their respective caregivers. Significant 
correlations have been demonstrated between the NHQ and a number of standard rating scales and in 
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particular the objective monitoring, providing a strong evidence for its validity in capturing the full 
spectrum of nocturnal hypokinesia in PD patients. 
  
One unique feature of the NHQ is that it can be completed by either PD patients or their caregivers, 
provided that he/she shares the same bedroom environment with the patient. Our data supports the 
use of proxy evaluation for nocturnal hypokinesia by caregivers, thus providing a practical 
application for physicians to acquire reliable night-time information from caregivers when the same 
information may not be obtained from patients for several reasons, for example patient’s inability to 
recall or communicate effectively [9, 10]. Indeed, the use of proxy evaluation in PD is not new and a 
successful example is shown by the proxy assessment of health-related quality of life using PD 
Questionnaire-8 and EuroQol-5 dimension [11]. To investigate about nocturnal hypokinesia in 
clinical practice, we recommend that the NHQ is provided to patients, particularly those who are at 
risk of developing night-time mobility problems, including those with a HY of at least stage 2 and 
the presence of day-time or early morning off [1]. The NHQ should be first attempted by patients but 
caregivers can be consulted for additional information or act as a proxy when patient’s information 
deems inadequate or unreliable. According to our own experience, the majority of patients and 
caregivers reported more than one aspect of nocturnal hypokinesia with a mean of four symptoms 
amongst moderate-stage patients. 
 
In addition to proxy evaluation, the NHQ offers several further advantages to its use in a clinical 
setting, including being a self-administered and simple instrument, which can be completed within 
10 minutes in the majority of PD patients. The ‘yes’ or ‘no’ response makes it a simple screening 
instrument that does not require detailed knowledge of responders for interpretation. The subjects 
were asked to complete the NHQ based on their experience within the past week, limiting the 
possibility of recall bias or error. As the NHQ evaluates different symptom dimensions of nocturnal 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 11
hypokinesia, the identified symptom can also be individually targeted for treatment. While the 
PDSS-2 is recommended as a screening tool and a measure of severity for overall sleep impairment, 
it is not an ideal scale for comprehensive assessment of nocturnal hypokinesia [6]. However, the 
PDSS-2 and NHQ can complement each other where the PDSS-2 is used to evaluate overall night-
time disturbances in PD patients, followed by a specific assessment of nocturnal hypokinesia by the 
NHQ when the PDSS-2 item on nocturnal immobility is identified to be frequent or troublesome to 
the patients. Since there is currently no gold standard for diagnosing nocturnal hypokinesia, a cut-off 
point for the NHQ cannot be determined, but the score range reflects the number of symptoms that 
are considered relevant to nocturnal hypokinesia. Uneven gender distribution, reflected by male 
predominance in both patients (60.5%) and control subjects (63.2%) could be a potential limitation 
although no statistical differences were found when compared between these two groups. Another 
limitation of our questionnaire is a lack of non-motor assessment of night-time symptoms (e.g. sleep 
dysfunctions, urinary symptoms), which may co-exist in PD patients with nocturnal hypokinesia. 
Future studies are needed to explore the relationship between nocturnal non-motor symptoms and 
nocturnal hypokinesia to provide a holistic approach of night-time symptoms in PD. 
  
To conclude, nocturnal hypokinesia represents one of many common night-time PD symptoms that 
are deemed by many patients as disabling to their quality of life, but potentially neglected by 
physicians [1, 12]. While no specific instrument is currently available for the evaluation of night-
time motor symptoms, the NHQ could be offered as a self-rated instrument by patients who are 
suspected of suffering from nocturnal hypokinesia with proxy evaluation by caregivers when direct 
patient’s information is not possible. The NHQ can also be considered as a screening tool for those 
with night-time motor problems [1]. The presence of nocturnal hypokinesia as identified by the NHQ 
should prompt physicians to investigate causes and coexisting nocturnal symptoms in their patients, 
and, importantly, to consider therapeutic options where indicated.  
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Table 1: Clinical demographics of Parkinson’s disease patient-caregiver pairs and healthy couples 
 Patient-caregiver pairs Healthy couples (C)  p-value  
PD patients  
(N=76)  
Caregivers 
(N=76)  
Control  
(N=76)  
Caregivers 
 
(N=76)  
Age (years)  65.59 ± 10.90 55.03 ± 16.06 64.30± 12.11 52.08 ± 15.83 pA = 0.681β, pB = 0.299β 
Male gender  46 (60.5) 18 (23.7) 48 (63.2) 13 (17.1) pA =0.738£, pB =0.314£ 
Relationship between caregivers 
and patients  
 
Spouses: 52 (68.4%) 
Senior caregivers: 9 (11.8%) 
Children: 12 (15.8%) 
Relatives: 3 (3.9%) 
Spouse 58 (76.3%) 
Senior caregivers 1 (1.3%) 
Children 14 (18.4%) 
Relatives 3 (3.9%) 
 
p=0.076£ 
Hoehn and Yahr score  2.62 ± 0.93 - - 
Categories of Hoehn and Yahr 
score  
Stage 1: 3 (3.9%) 
Stage 1.5: 10 (13.2) 
Stage 2: 16 (21.1%) 
Stage 2.5: 15 (19.7%) 
Stage 3: 19 (25%) 
Stage 4: 10 (13.2%) 
Stage 5: 3 (3.9%) 
 
- - 
Disease duration (years) 6.43 ± 2.96 - - 
LED (mg) 
 
965.60 ± 464.82 - - 
Total PDSS-2 score 
 
18.59 ± 9.31  - - 
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• Domain 1: Motor 
symptoms at night 
 
4.85 ± 4.31  - - 
• Domain 2: PD 
symptoms at night           
 
5.41 ± 4.42 - - 
• Domain 3: Disturb 
sleep 
 
8.31 ± 3.53 - - 
Total NADCS score 3.93 ± 3.02 - - 
NADCS–akinesia sub-score 2.02 ± 1.31 - - 
NADCS–dystonia sub-score 0.95 ± 1.27 - - 
NADCS–cramp sub-score 0.96 ± 1.17 - - 
*: Statistically significant; β: Mann-Whitney U test; £: Chi-square test; Values in parentheses indicate percentage; A: Comparison between PD 
patients and control subjects; B: Comparison between PD caregivers and control spouses; LED: Levodopa equivalent dose; PDSS-2: Modified 
Parkinson’s Disease Sleep Scale; NADCS: Nocturnal Akinesia Dystonia and Cramp Score.  
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Table 2: Nocturnal hypokinesia questionnaire scores of patient-caregiver pairs and healthy couples 
  
 Patient-caregiver pairs Healthy couples  p-value  
PD patients  
(N=76)  
Caregivers 
(N=76)  
Control  
(N=76)  
Spouses 
 
(N=76)  
Total NHQ score (points)  4.57± 2.54 4.28 ± 2.40 0.80 ± 1.24 0.80 ± 1.28 pA= 0.45β, pB= 0.84β 
pC<0.001β*, pD<0.001β* 
 
NHQ domain 1 score (Turning 
in bed, points)  
1.17± 0.86 1.06 ± 0.81 0.10 ± 0.35 0.11 ± 0.36 pA= 0.39β, pB=0.78β 
pC<0.001β*, pD<0.001β* 
NHQ domain 2 score (Getting 
out of bed, points)  
1.01± 0.86 0.98 ± 0.82 0.19 ± 0.54 0.26  ± 0.62 pA=0.84 β, pB=0.49β 
pC<0.001β*, pD<0.001β* 
NHQ domain 3 score 
(Parkinsonian motor symptoms, 
points)  
2.32 ± 1.52 2.24 ± 1.53 0.48 ± 0.77 0.42 ± 0.69 pA= 0.69β, pB=0.67β 
pC<0.001β*, pD<0.001β* 
NHQ domain 4 score (Others, 
points)  
0.05± 0.22 0.04 ± 0.19 0.01 ± 0.11 0.00 ± 0.00 pA= 0.71β, pB=0.31β 
pC=0.17β*, pD=0.07β* 
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*: Statistically significant; β: Mann-Whitney U test; A: Comparison between PD patients and caregivers; B: Comparison within control group; C: 
Comparison between PD patients and control subjects; D: Comparison between PD caregivers and control spouses; NHQ: Nocturnal hypokinesia 
questionnaire 
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Highlights:  
 
• There are no validated questionnaires to assess nocturnal hypokinesia in practice. 
• Our objective is to develop and validate the questionnaire for nocturnal hypokinesia. 
• The NHQ consists of 10 items, rated independently by patients and caregivers. 
• Our study confirms the internal and external validity of the NHQ in PD patients. 
• The NHQ is a reliable instrument to identify NH symptoms amongst PD patients.  
 
